• 1
    Jimenez-Sanchez G, Childs B, Valle D. Human disease genes. Nature 2001; 409: 8535.
  • 2
    Pearson E, Hattersley A. Genetic aetiology alters response to treatment in diabetes. Diabet Med 2003; 20: 12.
  • 3
    Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet 2001; 17: 50210.
  • 4
    Pritchard LE, Kawaguchi Y, Reed PW et al. Analysis of the CD3 gene region and type 1 diabetes: application of fluorescence-based technology to linkage disequilibrium mapping. Hum Mol Genet 1995; 4: 197202.
  • 5
    Terwilliger JD, Haghighi F, Hiekkalinna TS, Goring HH. A biased assessment of the use of SNPs in human complex traits. Curr Opin Genet Dev 2002; 12: 72634.
  • 6
    Pritchard JK, Cox NJ. The allelic architecture of human disease genes: common disease-common variant or not? Hum Mol Genet 2002; 11: 241723.
  • 7
    Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human diseases: true linkage is hard to find. Am J Hum Genet 2001; 69: 93650.
  • 8
    Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 151617.
  • 9
    Redondo MJ, Fain PR, Eisenbarth GS. Genetics of type 1A diabetes. In: MeansAR, ed. Recent Progress in Hormone Research, Vol. 56. Chevy Chase, MD: The Endocrine Society, 2001; 6989.
  • 10
    Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 4561.
  • 11
    Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003; 33: 17782.
  • 12
    Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARg Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 7680.
  • 13
    Gloyn AL, Weedon MN, Owen KR et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 2003; 52: 56872.
  • 14
    Barrett JC, Cardon LR. Evaluating coverage of genome-wide association studies. Nat Genet 2006; 38: 65962.
  • 15
    Pe’er I, De Bakker PIW, Maller J, Yelensky R, Altshuler D, Daly MJ. Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet 2006; 38: 6637.
  • 16
    Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007; 39: 906.
  • 17
    The Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447: 661.
  • 18
    Zeggini E, Weedon MN, Lindgren CM et al. Replication of genome-wide association signals in U.K. Samples reveals risk loci for type 2 diabetes. Science 2007; 316: 133641.
  • 19
    Scott LJ, Mohlke KL, Bonnycastle LL et al. A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants. Science 2007; 316: 13415.
  • 20
    Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University and Novartis Institutes for BioMedical Research, Saxena R, Voight BF et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007; 316: 13316.
  • 21
    Sladek R, Rocheleau G, Rung J et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007; 445: 881.
  • 22
    Steinthorsdottir V, Thorleifsson G, Reynisdottir I et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007; 39: 7705.
  • 23
    Grant SFA, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 3203.
  • 24
    Wolfel T, Hauer M, Schneider J et al. A P16(Ink4a)-insensitive Cdk4 mutant targeted by cytolytic T-lymphocytes in a human-melanoma. Science 1995; 269: 12814.
  • 25
    Rane SG, Dubus P, Mettus RV et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999; 22: 4452.
  • 26
    Krishnamurthy J, Ramsey MR, Ligon KL et al. p16(INK4a) induces an age-dependent decline in islet regenerative potential. Nature 2006; 443: 4537.
  • 27
    Moritani M, Yamasaki S, Kagami M et al. Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta 1. Mol Cell Endocrinol 2005; 229: 17584.
  • 28
    Bort R, Martinez-Barbera JP, Beddington RSP, Zaret KS. Hex homeobox gene-dependent tissue positioning is required for organogenesis of the ventral pancreas. Development 2004; 131: 797806.
  • 29
    Bogue CW, Ganea GR, Sturm E, Ianucci R, Jacobs HC. Hex expression suggests a role in the development and function of organs derived from foregut endoderm. Dev Dyn 2000; 219: 849.
  • 30
    Papadopoulou S, Edlund H. Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005; 54: 284451.
  • 31
    Smith U. TCF7L2 and type 2 diabetes – we WNT to know (Commentary). Diabetologia 2007; 50: 57.
  • 32
    Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 88994.
  • 33
    Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004; 137: 48695.
  • 34
    Christen WG, Glynn RJ, Manson JE, Ajani UA, Buring JE. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996; 276: 114751.
  • 35
    Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996; 276: 11416.
  • 36
    Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 3859.
  • 37
    Maller J, George S, Purcell S et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet 2006; 38: 10559.
  • 38
    Hampe J, Franke A, Rosenstiel P et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007; 39: 20711.
  • 39
    Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007; 39: 596.
  • 40
    Crawford ED. Epidemiology of prostate cancer. Urology 2003; 62: 312.
  • 41
    Yeager M, Orr N, Hayes RB et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39: 645.
  • 42
    Van Duin M, Van Marion R, Vissers K et al. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 2005; 44: 43849.
  • 43
    Thom T, Haase N, Rosamond W et al. Heart Disease and Stroke Statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85151.
  • 44
    Helgadottir A, Thorleifsson G, Manolescu A et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007; 316: 14913.
  • 45
    McPherson R, Pertsemlidis A, Kavaslar N et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007; 316: 148891.
  • 46
    Meyer UA. Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 2004; 5: 66976.
  • 47
    Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. Br Med J 2004; 329: 1519.
  • 48
    Hattersley AT, Pearson ER. Minireview: Pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 2006; 147: 265763.
  • 49
    Pearson ER, Liddell WG, Shepherd M, Corrall RJ, Hattersley AT. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor 1 alpha gene mutations: evidence for pharmacogenetics in diabetes. Diabet Med 2000; 17: 54345.
  • 50
    Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362: 127581.
  • 51
    Pearson ER, Donnelly L, Doney ASF et al. Pharmacogenetics in Type 2 diabetes: variation in TCF7L2 influences response to sulphonylureas. Diabet Med 2007; 24: 129.
  • 52
    Janssens A, Pardo MC, Steyerberg EW, Van Duijn CM. Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 2004; 74: 5858.
  • 53
    Weedon MN, McCarthy MI, Hitman G et al. Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 2006; 3: 187782.
  • 54
    Kruglyak L, Nickerson DA. Variation is the spice of life. Nat Genet 2001; 27: 2346.
  • 55
    Sachidanandam R, Weissman D, Schmidt SC et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 92833.
  • 56
    Hammond CJ, Webster AR, Snieder H, Bird AC, Gilbert CE, Spector TD. Genetic influence on early age-related maculopathy: A twin study. Ophthalmology 2002; 109: 7306.
  • 57
    Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US Twin Study of Age-Related Macular Degeneration: Relative Roles of Genetic and Environmental Influences. Arch Ophthalmol 2005; 123: 3217.
  • 58
    Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1998; 29: 9906.
  • 59
    Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer–analyses of cohorts of twins from Sweden, Denmark, and Finland. New Eng J Med 2000; 343: 7885.
  • 60
    Poulsen P, Ohm Kyvik K, Vaag A, Beck-Nielsen H. Heritability of Type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance – a population-based twin study. Diabetologia 1999; 42: 13945.
  • 61
    Henkin L, Bergman RN, Bowden DW, Ellsworth DL, Haffner SM, Langefeld CD, Mitchell BD, Norris JM, Rewers M, Saad MF, Stamm E, Wagenknecht LE, Rich SS. Genetic Epidemiology of Insulin Resistance and Visceral Adiposity: The IRAS Family Study Design and Methods. Ann Epidemiol 2003; 13: 2117.
  • 62
    Coady SA, Jaquish CE, Fabsitz RR, Larson MG, Cupples LA, Myers RH. Genetic Variability of Adult Body Mass Index: A Longitudinal Assessment in Framingham Families. Obesity Res 2002; 10: 67581.
  • 63
    Fischer M, Broeckel U, Holmer S, Baessler A, Hengstenberg C, Mayer B, Erdmann J, Klein G, Riegger G, Jacob HJ, Schunkert H. Distinct Heritable Patterns of Angiograpic Coronary Artery Disease in Families with Myocardial Infarction. Circulation 2005; 111: 85562.
  • 64
    Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002; 252: 24754.
  • 65
    Robinson RF, Batisky DL, Hayes JR, Nahata MC, Mahan JD. Significance of Heritability in Primary and Secondary Pediatric Hypertension. Am J Hypertens 2005; 18: 91721.
  • 66
    Gudmundsson J, Sulem P, Manolescu A et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007; 39: 6317.
  • 67
    Janssens A, Aulchenko YS, Elefante S, Borsboom G, Steyerberg EW, Van Duijin CM. Predictive testing for complex diseases using multiple genes: Fact or fiction? Genetics in Medicine 2006; 8: 395400.